Gastroenterology Practice Questions

Q: Hereditary pancreatitis is characterised by all except?

Autosomal recessive inheritance. **Explanation:** Hereditary Pancreatitis is a rare genetic condition characterized by recurrent episodes of acute pancreatitis starting in childhood, often progressing to chronic pancreatitis. **1. Why Option D is the Correct Answer (The Exception):** Hereditary pancreatitis is primarily an **Autosomal Dominant** condition, not recessive. The most common cause is a mutation in the **PRSS1 gene** (cationic trypsinogen gene) on chromosome 7. This mutation prevents the deactivation of trypsin within the pancreas, leading to premature enzyme activation and autodigestion. **2. Analysis of Other Options:** * **Option A (30% leads to Chronic Pancreatitis):** This is a recognized clinical progression. Recurrent inflammatory insults lead to permanent structural damage, calcification, and exocrine/endocrine insufficiency in a significant portion of patients. * **Option B (80% penetrance):** The PRSS1 mutation exhibits high but incomplete penetrance, typically cited around 80%. This means 80% of individuals carrying the gene will manifest clinical symptoms. * **Option C (High risk for Pancreatic cancer):** This is a critical clinical feature. Patients have a **50- to 70-fold increased risk** of developing pancreatic adenocarcinoma. The cumulative risk of cancer by age 70 is estimated to be nearly 40%. **Clinical Pearls for NEET-PG:** * **Gene Mutation:** PRSS1 (most common), SPINK1 (associated with tropical pancreatitis), and CFTR. * **Diagnosis:** Suspect in patients with two or more family members with pancreatitis across two generations. * **Management:** Primarily supportive; however, due to the extreme cancer risk, total pancreatectomy with auto-islet cell transplantation is sometimes considered. * **Screening:** Annual screening for pancreatic cancer (using EUS or MRI) is recommended starting at age 40.

Q: Which of the following is the established biological therapy for Crohn's disease?

Anti TNF-alpha antibody. **Explanation:** **1. Why Anti-TNF-alpha is Correct:** Tumor Necrosis Factor-alpha (TNF-α) is a key pro-inflammatory cytokine that plays a central role in the pathogenesis of Crohn’s disease by inducing intestinal inflammation and mucosal damage. Biological therapies targeting TNF-α (e.g., **Infliximab, Adalimumab, Certolizumab**) have revolutionized management. They work by neutralizing soluble and membrane-bound TNF-α, inducing apoptosis of inflammatory cells, and promoting mucosal healing. These are indicated for moderate-to-severe Crohn’s disease, especially in patients refractory to conventional steroids or thiopurines [1]. **2. Why the Other Options are Incorrect:** * **IL-1 Antagonist (Anakinra):** While IL-1 is involved in general inflammation, its antagonists have not shown clinical efficacy in Crohn’s disease and are primarily used in Rheumatoid Arthritis or Autoinflammatory syndromes. * **IL-6 Antagonist (Tocilizumab):** Although IL-6 levels are elevated in IBD, clinical trials have not established IL-6 inhibition as a standard therapy for Crohn’s; it is mainly used in Rheumatoid Arthritis and Giant Cell Arteritis. * **IL-8 Antagonist:** IL-8 is a potent neutrophil chemoattractant, but it is not a target for any currently approved biological therapy for IBD. **3. NEET-PG High-Yield Pearls:** * **First-line Biological:** Infliximab is often the first biological used, especially for **fistulizing Crohn’s disease**. * **Other Biological Targets:** Apart from Anti-TNF, other approved biologics include **Vedolizumab** (Anti-α4β7 integrin) and **Ustekinumab** (Anti-IL-12/23). * **Pre-treatment Screening:** Before starting Anti-TNF therapy, always screen for **Latent Tuberculosis (Chest X-ray, TST/IGRA)** and **Hepatitis B**, as these drugs can cause reactivation. * **Side Effects:** Increased risk of opportunistic infections and lymphoma (especially when combined with azathioprine).

Q: Which of the following conditions is characterized by indirect hyperbilirubinemia?

Gilbert syndrome. The classification of jaundice depends on whether the elevation is in **unconjugated (indirect)** or **conjugated (direct)** bilirubin. [1] **Correct Answer: C. Gilbert syndrome** Gilbert syndrome is a common, benign autosomal recessive condition characterized by reduced activity of the enzyme **UDP-glucuronosyltransferase (UGT1A1)**. [1] This enzyme is responsible for conjugating bilirubin in the liver. A deficiency leads to impaired conjugation, resulting in isolated **indirect (unconjugated) hyperbilirubinemia**. [1] Jaundice is typically mild and triggered by stress, fasting, or illness. **Incorrect Options:** * **A & B (Dubin-Johnson and Rotor syndromes):** These are hereditary disorders characterized by impaired biliary excretion of bilirubin from the hepatocytes into the bile canaliculi. Therefore, they result in **conjugated (direct) hyperbilirubinemia**. * **D (Gallstone):** This causes obstructive (post-hepatic) jaundice. [2] Since the bilirubin has already been processed by the liver, the obstruction leads to a backup of **conjugated (direct) bilirubin** into the bloodstream. [2] **High-Yield Clinical Pearls for NEET-PG:** * **Crigler-Najjar Syndrome:** Also causes indirect hyperbilirubinemia. Type I is a total absence of UGT1A1 (severe, kernicterus), while Type II (Arias syndrome) is a partial deficiency. [1] * **Dubin-Johnson vs. Rotor:** Dubin-Johnson is associated with a **black liver** (due to melanin-like pigment) and normal urinary coproporphyrin levels but an abnormal ratio (80% Coproporphyrin I). Rotor syndrome does not have a pigmented liver. * **Gilbert Syndrome Diagnosis:** Usually an incidental finding; liver function tests (ALT, AST, ALP) and biopsy are normal. Reticulocyte count is normal (ruling out hemolysis).

Q: Which is the most important complication of celiac sprue?

Intestinal neoplasm. The most serious and life-threatening complication of long-standing Celiac disease (especially in patients non-compliant with a gluten-free diet) is the development of malignancies [1]. The most characteristic neoplasm is **Enteropathy-Associated T-cell Lymphoma (EATL)**, which typically involves the proximal small bowel [1]. Other associated malignancies include small bowel adenocarcinoma and squamous cell carcinoma of the esophagus. The risk is significantly higher in patients with "Refractory Celiac Disease." **2. Analysis of Incorrect Options:** * **B. Diabetes Mellitus:** Type 1 Diabetes is an **associated autoimmune condition** (sharing the HLA-DQ2/DQ8 linkage) rather than a complication caused by Celiac disease itself. * **C. Dermatitis Herpetiformis:** This is the **cutaneous manifestation** of Celiac disease, characterized by pruritic vesicles on extensor surfaces. It is considered part of the disease spectrum, not a complication. * **D. Bile Acid Diarrhea:** While malabsorption occurs in Celiac disease, bile acid diarrhea is more typically a complication of terminal ileal resection or Crohn’s disease, where bile acid reabsorption is impaired. **3. NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Small intestinal biopsy showing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes (Marsh Classification) [1]. * **Serology:** Anti-tissue Transglutaminase (anti-tTG) IgA is the screening test of choice. Anti-Endomysial antibody (EMA) is the most specific. * **Genetics:** Strongly associated with **HLA-DQ2** (95%) and **HLA-DQ8** [1]. * **Refractory Disease:** If symptoms persist despite a gluten-free diet, suspect EATL or Ulcerative Jejunoileitis [1].

Q: Eradication of H. pylori has been proved to be beneficial in which of the following conditions except?

Hypertrophic gastritis. The eradication of *Helicobacter pylori* is a cornerstone in the management of several acid-peptic and lymphoproliferative disorders [1]. However, it has no proven therapeutic benefit in **Hypertrophic gastritis** (Option D). [2] **1. Why Hypertrophic Gastritis is the Correct Answer:** Hypertrophic gastritis (specifically **Ménétrier's disease**) is characterized by massive overgrowth of mucous cells (foveolar hyperplasia) in the gastric body, leading to large rugal folds and protein-losing enteropathy. The underlying pathophysiology is linked to the over-expression of **Transforming Growth Factor-alpha (TGF-α)**, not *H. pylori* infection. Therefore, eradication therapy does not reverse the pathology. **2. Analysis of Incorrect Options:** * **Duodenal (A) and Gastric Ulcers (B):** *H. pylori* is the most common cause of peptic ulcer disease (PUD) [1]. Eradication therapy significantly promotes ulcer healing and, more importantly, reduces the rate of recurrence from >70% to <5% [1]. * **Low-grade MALT Lymphoma (C):** This is a high-yield fact. Gastric MALT lymphoma is uniquely dependent on the antigenic stimulation provided by *H. pylori* [1]. In early-stage (low-grade) cases, *H. pylori* eradication alone can lead to complete regression of the tumor in up to 70-80% of patients [1]. **Clinical Pearls for NEET-PG:** * **Definite Indications for Eradication:** PUD (active or healed), MALT lymphoma, and early gastric cancer (post-resection). * **Ménétrier's Disease:** Look for the triad of **large rugal folds**, **hypoalbuminemia** (protein loss), and **achlorhydria**. It is a premalignant condition. * **First-line Treatment:** Standard Triple Therapy (Clarithromycin + Amoxicillin + PPI) for 14 days is the conventional choice, though Bismuth-based Quadruple Therapy is increasingly preferred due to resistance.

Q: An 82-year-old woman with a history of a small hiatus hernia was recently diagnosed with osteoporosis and started on treatment. Three months later, she presents with progressive dysphagia to solids, particularly meat. She has lost 3 kg in weight but retains a good appetite. What is the most likely explanation for her symptoms?

Side effect of bisphosphonate therapy for osteoporosis. **Explanation:** The patient’s presentation is highly suggestive of **pill-induced esophagitis** leading to an **esophageal stricture**, a well-documented complication of oral **bisphosphonates** (e.g., Alendronate). **1. Why the Correct Answer is Right:** Bisphosphonates are notorious for causing direct mucosal irritation. In elderly patients with a **hiatus hernia**, the drug may linger in the esophagus due to impaired clearance or reflux [1]. Chronic chemical irritation leads to inflammation, ulceration, and eventually, the formation of a **benign peptic stricture** [1]. This manifests as progressive dysphagia to solids (like meat) while the appetite remains intact. **2. Why Incorrect Options are Wrong:** * **A. Early esophageal cancer:** While weight loss and dysphagia in an 82-year-old raise suspicion for malignancy, the specific temporal relationship (starting osteoporosis treatment 3 months prior) and the presence of a predisposing factor (hiatus hernia) point more strongly toward a drug-induced complication. * **B. Eosinophilic esophagitis:** This typically presents in younger males with a history of atopy (asthma/allergies). While it causes solid-food dysphagia, it is less likely in an 82-year-old female. * **C. Plummer-Vinson syndrome:** This is characterized by the triad of iron-deficiency anemia, glossitis, and esophageal webs. It usually affects middle-aged women and is not associated with bisphosphonate use. **Clinical Pearls for NEET-PG:** * **Prevention:** Patients taking oral bisphosphonates must remain **upright for at least 30–60 minutes** and take the pill with a full glass of water to prevent stasis. * **Common Culprits for Pill Esophagitis:** Bisphosphonates, Tetracyclines (Doxycycline), NSAIDs, and Potassium Chloride. * **Diagnosis:** Upper GI endoscopy is the gold standard to visualize the stricture/ulcer and rule out malignancy [2].

Q: Hepatitis C virus (HCV) infection is associated with which of the following?

Anti-liver kidney microsome (LKM) antibody. ### Explanation **Correct Option: B. Anti-liver kidney microsome (LKM) antibody** Hepatitis C Virus (HCV) infection is frequently associated with various extrahepatic manifestations and immunological abnormalities. Specifically, **Anti-LKM-1 antibodies** (directed against cytochrome P450 2D6) are found in approximately **5–10% of patients with chronic HCV** [1]. The underlying mechanism is thought to be **molecular mimicry**, where the immune system reacts to HCV proteins that share structural similarities with the LKM-1 antigen. This is clinically significant because it can mimic Type 2 Autoimmune Hepatitis (AIH), making it crucial to differentiate between the two before starting interferon therapy, which can exacerbate underlying autoimmunity [1]. **Analysis of Incorrect Options:** * **A. Autoimmune cirrhosis:** While HCV can trigger autoimmune-like features, "Autoimmune cirrhosis" is the end-stage of Autoimmune Hepatitis (AIH). HCV is a viral infection, not an autoimmune disease, though it may coexist with or trigger AIH in genetically susceptible individuals. * **C. Antimitochondrial antibody (AMA):** AMA is the hallmark serological marker for **Primary Biliary Cholangitis (PBC)** [2]. It is highly specific (95%) for PBC and is not typically associated with HCV infection. **High-Yield Clinical Pearls for NEET-PG:** * **LKM-1:** Associated with **Type 2 Autoimmune Hepatitis** and **HCV** [1]. * **LKM-2:** Associated with **Drug-induced hepatitis** (e.g., Ticrynafen). * **LKM-3:** Associated with **Hepatitis D (HDV)**. * **Extrahepatic manifestations of HCV:** Cryoglobulinemia (most common), Membranoproliferative glomerulonephritis (MPGN), Porphyria cutanea tarda, and Lichen planus.

Question 1

Hereditary pancreatitis is characterised by all except?

Accepted Answer

Autosomal recessive inheritance

Answer

30% leads to Chronic Pancreatitis

Answer

80% penetrance

Answer

High risk for Pancreatic cancer

Question 2

Transjugular intrahepatic portosystemic shunt (TIPS) is used in all except?

Accepted Answer

Hepatopulmonary syndrome

Answer

Refractory ascites

Answer

Budd-Chiari syndrome

Answer

Refractory hepatic hydrothorax

Question 3

Which of the following is the established biological therapy for Crohn's disease?

Accepted Answer

Anti TNF-alpha antibody

Answer

IL-1 antagonist

Answer

IL-6 antagonist

Answer

IL-8 antagonist

Question 4

Which of the following conditions is characterized by indirect hyperbilirubinemia?

Accepted Answer

Gilbert syndrome

Answer

Dubin-Johnson syndrome

Answer

Rotor syndrome

Answer

Gallstone

Question 5

Which is the most important complication of celiac sprue?

Accepted Answer

Intestinal neoplasm

Answer

Diabetes mellitus

Answer

Dermatitis herpetiformis

Answer

Bile acid diarrhea

Question 6

Eradication of H. pylori has been proved to be beneficial in which of the following conditions except?

Accepted Answer

Hypertrophic gastritis

Answer

Duodenal ulcer

Answer

Gastric ulcer

Answer

Low grade MALT lymphoma

Question 7

An 82-year-old woman with a history of a small hiatus hernia was recently diagnosed with osteoporosis and started on treatment. Three months later, she presents with progressive dysphagia to solids, particularly meat. She has lost 3 kg in weight but retains a good appetite. What is the most likely explanation for her symptoms?

Accepted Answer

Side effect of bisphosphonate therapy for osteoporosis

Answer

Early esophageal cancer

Answer

Eosinophilic esophagitis

Answer

Plummer-Vinson syndrome

Question 8

Which of the following statements is true regarding viral hepatitis?

Accepted Answer

Transaminase levels show variable elevation during the prodromal phase.

Answer

Raised transaminase levels correlate well with the extent of hepatic injury.

Answer

Hepatitis A virus (HAV) infection is diagnosed by estimating IgG antibodies.

Answer

Elevation of transaminases is specific for liver injury.

Question 9

Hepatitis C virus (HCV) infection is associated with which of the following?

Accepted Answer

Anti-liver kidney microsome (LKM) antibody

Answer

Autoimmune cirrhosis

Answer

Antimitochondrial antibody

Answer

None of the above

Question 10

Protein losing enteropathy with mucosal erosion is seen in which of the following conditions?

Accepted Answer

Lymphoma

Answer

Coeliac disease

Answer

Menetrier's disease

Answer

Systemic lupus erythematosus

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?